This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Cyprus, Estonia, Finland, Germany, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Nigeria, Poland, Romania, Singapore, UK.
The drug NIZORAL contains one active pharmaceutical ingredient (API):
1
|
UNII
R9400W927I - KETOCONAZOLE
|
Ketoconazole is an imidazole-dioxolane antimycotic, active against yeasts, including Malassezia and dermatophytes. |
|
Below package inserts are available for further reading:
Document | Type | Information Source | |
---|---|---|---|
NIZORAL Shampoo | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC Group | Classification | |
---|---|---|
D01AC08 | Ketoconazole | D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AC Imidazole and triazole derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
AU | Pharmaceutical Benefits Scheme | 1574W, 9024Y |
BR | Câmara de Regulação do Mercado de Medicamentos | 514502603161319 |
CA | Health Products and Food Branch | 02182920 |
DE | Bundesinstitut für Arzneimittel und Medizinprodukte | 03265207, 03265213, 09289628, 09289640, 13889819, 13889825 |
EE | Ravimiamet | 1018189, 1060940, 1060951, 1060984, 1821204, 1843736, 1850116 |
FI | Lääkealan turvallisuus- ja kehittämiskeskus | 393957, 454689, 522237 |
GB | Medicines & Healthcare Products Regulatory Agency | 27623, 27655, 27660, 377406, 381563, 80674 |
HK | Department of Health Drug Office | 31551 |
IE | Health Products Regulatory Authority | 46094, 76333, 76350 |
IL | מִשְׂרַד הַבְּרִיאוּת | 1397, 2491 |
JP | 医薬品医療機器総合機構 | 2655709N1053, 2655709Q1025 |
LT | Valstybinė vaistų kontrolės tarnyba | 1013162, 1014156, 1063038, 1066508, 1070167, 1075377, 1075481, 1082478, 1083391, 1089259, 1091909, 1092604, 1093129, 1093130 |
MT | Medicines Authority | MA830/00401, MA830/00402, PI1438/07301A, PI521/08402A, PI908/06601A |
MX | Comisión Federal para la Protección contra Riesgos Sanitarios | 209M83, 295M89, 94M83 |
NG | Registered Drug Product Database | 04-1733, 04-1734 |
NL | Z-Index G-Standaard | 12811599 |
NL | Z-Index G-Standaard, PRK | 23264 |
NZ | Medicines and Medical Devices Safety Authority | 3393, 3394, 3395 |
PL | Rejestru Produktów Leczniczych | 100047790, 100047808, 100260710, 100260761, 100264687, 100266812, 100292318, 100327459, 100353630, 100356892, 100363202, 100366264, 100368122, 100413905, 100451660 |
RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W57514001, W57514002 |
SG | Health Sciences Authority | 01117P, 04926P |
US | FDA, National Drug Code | 50458-680 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.